Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 29, 2025
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at the …
Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities
GlobeNewswire
·
May 29, 2025
EVANSTON, Ill., May 29, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that highly-regarded industry leaders Robert Rouse and Jason Stephani …
Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
GlobeNewswire
·
May 29, 2025
CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company’s virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the …
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …
Replimune to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will …
Alarum Technologies Announces First Quarter 2025 Results
GlobeNewswire
·
May 29, 2025
Q1 2025 highlighted the growing traction of the company’s data collection solutions with leading AI and eCommerce players worldwide Company strategically accelerated investments in scalable infrastructure and next-gen technologies to meet the rising demand …
Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
GlobeNewswire
·
May 29, 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced the appointment …
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
BOS Reports Record $15 Million in Revenues for the First Quarter of 2025
GlobeNewswire
·
May 29, 2025
RISHON LE ZION, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC) reported its financial results for the first quarter of the year 2025. First Quarter 2025 Financial Highlights: Revenues …
Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
Bitcoin Solaris Announces Official Presale Launch: A New Era in DeFi Begins
GlobeNewswire
·
May 29, 2025
TALLINN, Estonia, May 29, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S) has officially launched its highly anticipated presale, marking the beginning of a new chapter in decentralized finance. With groundbreaking technology, mobile mining accessibility, …
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
GlobeNewswire
·
May 29, 2025
Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”, the “Company” or “we”) (Nasdaq: …
Azimut and KGHM Launch Exploration Campaign at Kukamas
GlobeNewswire
·
May 29, 2025
LONGUEUIL, Quebec, May 29, 2025 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to announce that a comprehensive partner-funded exploration program is commencing on the Kukamas Property (the “ …
Azimut et KGHM débutent la campagne d’exploration sur Kukamas
GlobeNewswire
·
May 29, 2025
LONGUEUIL, Québec, 29 mai 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV: AZM) (OTCQX: AZMTF) annonce qu’un vaste programme d’exploration financé par le partenaire débute sur la Propriété Kukamas (la « Propriété ») …
Integral Metals Announces Start of High-Resolution Soil Sampling Program at the KAP Project
GlobeNewswire
·
May 29, 2025
CALGARY, Alberta, May 29, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that the Phase 2 soil sampling program has officially commenced at the Company’s 100%-owned …